| Date | Time | Source | Headline | Symbol | Company |
| 08/12/2019 | 3:12PM | Edgar (US Regulatory) | Unknown (sec Staff) | NASDAQ:AEGR | Aegerion Pharmaceuticals, Inc. |
| 08/08/2019 | 12:03PM | Edgar (US Regulatory) | Amended Application for Qualification of Trust Indentures (t-3/a) | NASDAQ:AEGR | Aegerion Pharmaceuticals, Inc. |
| 07/19/2019 | 1:51PM | Edgar (US Regulatory) | Application for Qualification of Trust Indentures (t-3) | NASDAQ:AEGR | Aegerion Pharmaceuticals, Inc. |
| 02/14/2017 | 2:00PM | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:AEGR | Aegerion Pharmaceuticals, Inc. |
| 02/14/2017 | 10:22AM | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:AEGR | Aegerion Pharmaceuticals, Inc. |
| 02/08/2017 | 4:35PM | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:AEGR | Aegerion Pharmaceuticals, Inc. |
| 01/31/2017 | 3:43PM | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:AEGR | Aegerion Pharmaceuticals, Inc. |
| 12/12/2016 | 10:42AM | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:AEGR | Aegerion Pharmaceuticals, Inc. |
| 12/09/2016 | 4:07PM | Edgar (US Regulatory) | Termination of Registration of a Class of Security Under Section 12(b) (15-12b) | NASDAQ:AEGR | Aegerion Pharmaceuticals, Inc. |
| 12/09/2016 | 6:01AM | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:AEGR | Aegerion Pharmaceuticals, Inc. |
| 12/05/2016 | 6:02AM | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:AEGR | Aegerion Pharmaceuticals, Inc. |
| 12/01/2016 | 5:45PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AEGR | Aegerion Pharmaceuticals, Inc. |
| 12/01/2016 | 5:26PM | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:AEGR | Aegerion Pharmaceuticals, Inc. |
| 11/30/2016 | 3:32PM | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:AEGR | Aegerion Pharmaceuticals, Inc. |
| 11/29/2016 | 5:08PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:AEGR | Aegerion Pharmaceuticals, Inc. |
| 11/29/2016 | 4:26PM | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:AEGR | Aegerion Pharmaceuticals, Inc. |
| 11/29/2016 | 4:23PM | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:AEGR | Aegerion Pharmaceuticals, Inc. |
| 11/29/2016 | 4:23PM | Edgar (US Regulatory) | (25-NSE) | NASDAQ:AEGR | Aegerion Pharmaceuticals, Inc. |
| 11/29/2016 | 4:23PM | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:AEGR | Aegerion Pharmaceuticals, Inc. |
| 11/29/2016 | 4:23PM | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:AEGR | Aegerion Pharmaceuticals, Inc. |
| 11/29/2016 | 4:22PM | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:AEGR | Aegerion Pharmaceuticals, Inc. |
| 11/29/2016 | 4:22PM | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:AEGR | Aegerion Pharmaceuticals, Inc. |
| 11/29/2016 | 4:22PM | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:AEGR | Aegerion Pharmaceuticals, Inc. |
| 11/29/2016 | 12:10PM | GlobeNewswire Inc. | Aegerion Pharmaceuticals, Inc. and QLT Inc. Complete Merger Transaction; QLT to Change Name to Novelion Therapeutics Inc. | NASDAQ:AEGR | Aegerion Pharmaceuticals, Inc. |
| 11/17/2016 | 4:15PM | GlobeNewswire Inc. | Aegerion Pharmaceuticals’ JUXTAPID® (lomitapide) Capsules for the Treatment of Homozygous Familial Hypercholesterolemia (H... | NASDAQ:AEGR | Aegerion Pharmaceuticals, Inc. |
| 11/16/2016 | 6:01AM | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | NASDAQ:AEGR | Aegerion Pharmaceuticals, Inc. |
| 11/07/2016 | 5:40PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:AEGR | Aegerion Pharmaceuticals, Inc. |
| 11/04/2016 | 5:34PM | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:AEGR | Aegerion Pharmaceuticals, Inc. |
| 11/04/2016 | 4:03PM | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:AEGR | Aegerion Pharmaceuticals, Inc. |
| 11/03/2016 | 5:21PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:AEGR | Aegerion Pharmaceuticals, Inc. |